Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APGE Apogee Therapeutics

盘后交易 07-17 17:25:39 EDT

49.21

-0.87

-1.74%

盘后49.21

+0.000.00%

16:03 EDT

最高50.61	最低47.69	成交量49.00万
今开48.99	昨收50.08	日振幅5.84%
总市值28.77亿	流通市值13.93亿	总股本5,846万
成交额2,402万	换手率1.73%	流通股本2,830万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":49.21,"timestamp":1721246400000,"preClose":50.08,"halted":0,"volume":490032,"hourTrading":{"tag":"盘后","latestPrice":49.21,"preClose":49.21,"latestTime":"16:03 EDT","volume":13043,"amount":641846.03,"timestamp":1721246597866},"delay":0,"floatShares":28300339,"shares":58456027,"eps":-2.852473,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.87,"latestTime":"07-17 17:25:39 EDT","open":48.99,"high":50.61,"low":47.685,"amount":24015783.255264,"amplitude":0.058407,"askPrice":50.74,"askSize":100,"bidPrice":41.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.852473,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"listingDate":1689307200000,"adjPreClose":50.08,"postHourTrading":{"tag":"盘后","latestPrice":49.21,"preClose":49.21,"latestTime":"16:03 EDT","volume":13043,"amount":641846.03,"timestamp":1721246597866},"volumeRatio":0.781817,"impliedVol":0.6704,"impliedVolPercentile":0.5732},"requestUrl":"/m/hq/s/APGE","defaultTab":"news","newsList":[{"id":"2417239460","title":"美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2417239460","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417239460?lang=zh_cn&edition=full","pubTime":"2024-03-06 14:48","pubTimestamp":1709707680,"startTime":"0","endTime":"0","summary":"    路透社3月6日 - 华尔街证券分析师周三调整了对 Arrivent Biopharma、Ferguson 和 Target 等几家美国上市公司的评级和目标价。要闻             * Arrivent Biopharma Inc   ：杰富瑞给予买入评级             * 弗格森  ：杰富瑞将目标价从 222 美元上调至 244 美元             * Target Corp   ：汇丰银行将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EHAB","ATIP","LFST","NNN","NKTR","DYN","LU0348723411.USD","PLAY","BOX","BK4023","FLGT","BK4588","AVAV","HCP","MD","NTST","NTRA","APGE","ROST","TSLA","AXGN","LU2272731600.USD","STIM","NWPX","CRWD","JWN","CRGY","BK4144","LU0053666078.USD","LU0823411888.USD","VYX","TWLO","MCRB","BK4585","FWRG","LU1244550577.SGD","FERG","LU0823414478.USD","LU0082616367.USD","BASE","COLB","LII","LU2272731782.SGD","TRGP","IONS","TGT","SG","AVBP","CTKB","AGS"],"gpt_icon":0},{"id":"2417417822","title":"BUZZ-皮肤病药物数据良好，Apogee Therapeutics 创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2417417822","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417417822?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:59","pubTimestamp":1709650767,"startTime":"0","endTime":"0","summary":" (更新)    3月5日 - ** 药物开发商Apogee Therapeutics   股价上涨43%，创下59.4美元的历史新高** 公司表示，其治疗中重度特应性皮炎的主要候选药物之一 在一项早期研究中显示出疗效** 特应性皮炎通常被称为湿疹，是一种慢性疾病，会引起皮肤炎症、发红和刺激。** TD Cowen 分析师泰勒-范布伦在一份报告中写道，数据 \"超出了所有预期\"，并称这可能是一种价值十亿美元的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","BUZZ"],"gpt_icon":0},{"id":"2417492826","title":"BUZZ-皮肤病药物数据良好，Apogee Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2417492826","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417492826?lang=zh_cn&edition=full","pubTime":"2024-03-05 20:08","pubTimestamp":1709640537,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月5日 - ** Apogee Therapeutics   股价盘前上涨5.4%至44美元 ** 公司称其治疗中重度特应性皮炎的一种主要候选药物(AD) 在一项早期研究中显示出疗效 ** 特应性皮炎通常被称为湿疹，是一种慢性疾病，会引起皮肤炎症、发红和刺激。 ** 研究发现，抗体药物 APG777 安全且耐受性良好 -APGE ** 与目前批准的生物疗法相比，APG777 有可能大大减少用药次数 -APGE** 公司计划在今年上半年开始 APG777 的中期研究。** 截至上一交易日收盘，公司股价年累计上涨49.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","APGE","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apogeetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.2483},{"period":"1month","weight":0.2173},{"period":"3month","weight":-0.0276},{"period":"6month","weight":0.5558},{"period":"1year","weight":1.4077},{"period":"ytd","weight":0.7924}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apogee Therapeutics, Inc.于2023年6月9日作为一家特拉华州公司成立，与此次发行有关，作为一家控股公司，将全资拥有Apogee Therapeutics，LLC，并间接拥有其子公司。该公司是一家生物技术公司，致力于开发用于治疗特应性皮炎、慢性阻塞性肺病及相关炎症和免疫学适应症的差异化生物制剂，这些适应症的需求尚未得到满足。该公司的抗体项目旨在克服现有疗法的局限性，针对的是成熟的作用机制，并结合先进的抗体工程来优化半衰期和其他特性。","exchange":"NASDAQ","name":"Apogee Therapeutics","nameEN":"Apogee Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apogee Therapeutics,APGE,Apogee Therapeutics股票,Apogee Therapeutics股票老虎,Apogee Therapeutics股票老虎国际,Apogee Therapeutics行情,Apogee Therapeutics股票行情,Apogee Therapeutics股价,Apogee Therapeutics股市,Apogee Therapeutics股票价格,Apogee Therapeutics股票交易,Apogee Therapeutics股票购买,Apogee Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况